已收录 273524 条政策
 政策提纲
  • 暂无提纲
miR-103-3p regulates the differentiation of bone marrow mesenchymal stem cells in myelodysplastic syndrome"> miR-103-3p regulates the differentiation of bone marrow mesenchymal stem cells in myelodysplastic syndrome
[摘要] The pathogenesis of myelodysplastic syndrome (MDS) may be related to the abnormal expression of microRNAs(miRNAs), which could influence the differentiation capacity of mesenchymal stem cells (MSCs) towards adipogenic andosteogenic lineages. In this study, exosomes from bone marrow plasma were successfully extracted and identified.Assessment of miR-103-3p expression in exosomes isolated from BM in 34 MDS patients and 10 controls revealed its0.52-fold downregulation in patients with MDS compared with controls (NOR) and was downregulated 0.55-fold inMDS-MSCs compared with NOR-MSCs. Transfection of MDS-MSCs with the miR-103-3p mimic improved osteogenicdifferentiation and decreased adipogenic differentiation in vitro, while inhibition of miR-103-3p showed the oppositeresults in NOR-MSCs. Thus, the expression of miR-103-3p decreases in MDS BM plasma and MDS-MSCs, significantlyimpacting MDS-MSCs differentiation. The miR-103-3p mimics may boost MDS-MSCs osteogenic differentiation whileweakening lipid differentiation, thereby providing possible target for the treatment of MDS pathogenesis.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 仪器
[关键词] Myelodysplastic syndrome;Mesenchymal stem cells;miR-103-3p;Osteogenic differentiation;Adipogenic differentiation [时效性] 
   浏览次数:4      统一登录查看全文      激活码登录查看全文